- $100.69bn
- $124.02bn
- $19.09bn
- 95
- 33
- 95
- 87
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10,187 | 14,852 | 16,226 | 17,737 | 19,093 |
Cost of Revenue | |||||
Gross Profit | 4,926 | 7,040 | 8,098 | 9,745 | 11,423 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 8,625 | 13,000 | 13,938 | 13,997 | 14,079 |
Operating Profit | 1,562 | 1,852 | 2,288 | 3,740 | 5,014 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,083 | 1,171 | 1,666 | 2,913 | 3,898 |
Provision for Income Taxes | |||||
Net Income After Taxes | 885 | 975 | 1,303 | 2,362 | 3,144 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 893 | 958 | 1,334 | 2,530 | 3,068 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 893 | 958 | 1,334 | 2,530 | 3,068 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.97 | 1.52 | 2.25 | 4.09 | 4.76 |